Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...
The U.S. Food and Drug Administration (FDA) released a new plan on Tuesday to address the regulation of artificial intelligence (AI) machine learning (ML)-based software as medical devices (SaMD). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results